Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bluejay Diagnostics (BJDX) EBT Margin (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed EBT Margin for 2 consecutive years, with 5415.13% as the latest value for Q3 2023.

  • Quarterly EBT Margin changed N/A to 5415.13% in Q3 2023 from the year-ago period, while the trailing twelve-month figure was 3767.58% through Dec 2023, down 70149.0% year-over-year, with the annual reading at 817193.33% for FY2025, 81623992.0% up from the prior year.
  • EBT Margin hit 5415.13% in Q3 2023 for Bluejay Diagnostics, down from 3200.75% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 797.35% in Q2 2022 to a low of 5415.13% in Q3 2023.